Special Issue
Current advances in epilepsy and neurodegeneration
Submission Deadline: 31 December 2017
Articles: 6
Special Issue Editor
Guest Editor
Antoni Camins
Professor, Unitat de Farmacologia i Farmacognosia, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain, and Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Madrid, Spain
Expertise: 189 publications, 11 grants, Editor of Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see


Nervous System
Share This Special Issue
Published Papers (6 papers)
Open Access

Molecular links between early energy metabolism alterations and Alzheimer´s disease

Ignacio Pedros, Ivan Patraca, Nohora Martinez, Dmitry Petrov, Francesc X. Sureda, Carme Auladell, Carlos Beas-Zarate, Jaume Folch
Frontiers in Bioscience-Landmark Volume 21 Issue 1, pp.8-19
Managing Editor: Antoni Camins
DOI: 10.2741/4372 Published: 01 January 2016
Open Access

Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration

Carme Auladell, Luisa de Lemos, Ester Verdaguer, Miren Ettcheto, Oriol Busquets, Alberto Lazarowski, Carlos Beas-Zarate, Jordi Olloquequi, Jaume Folch, Antoni Camins
Frontiers in Bioscience-Landmark Volume 22 Issue 5, pp.795-814
Managing Editor: Antoni Camins
DOI: 10.2741/4517 Published: 01 January 2017
Open Access
Resveratrol in epilepsy: preventive or treatment opportunities?
Mercè Pallàs, Daniel Ortuño-Sahagún, Pol Andrés-Benito, María Dolores Ponce-Regalado, Argelia E Rojas-Mayorquín
Frontiers in Bioscience-Landmark Volume 19 Issue 7, pp.1057-1064
Managing Editor: Antoni Camins
DOI: 10.2741/4267 Published: 01 June 2014
Open Access
Calorie restriction and NAD⁺/sirtuin counteract the hallmarks of aging
Shaday Michan
Frontiers in Bioscience-Landmark Volume 19 Issue 8, pp.1300-1319
Managing Editor: Antoni Camins
DOI: 10.2741/4283 Published: 01 June 2014
Open Access
ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies
Lilliana Czornyj, Alberto Lazarowski
Frontiers in Bioscience-Landmark Volume 19 Issue 8, pp.1425-1435
Managing Editor: Antoni Camins
DOI: 10.2741/4293 Published: 01 June 2014
Open Access
From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin
Rolando Castaneda-Arellano, Carlos Beas-Zarate, Alfredo I Feria-Velasco, Emilio W Bitar-Alatorre, Martha C Rivera-Cervantes
Frontiers in Bioscience-Landmark Volume 19 Issue 8, pp.1445-1455
Managing Editor: Antoni Camins
DOI: 10.2741/4295 Published: 01 June 2014